Andy Batts
Growth at reasonable price, deep value, healthcare, tech

Align Technology: Buy This Orthodontics Pioneer In The Corrective Phase

Align Technology (NASDAQ:ALGN) is a provider of a modern system - Invisalign, which corrects malocclusion or misalignment of teeth. The stock of the company has corrected ~10% from the recent high of $60. According to fellow Seeking Alpha contributor Arizona Trader, Danaher Corporation (NYSE:DHR) just sold out a major stake (4.6 million shares) in Align for $54.60. In the last one year the stock has appreciated ~100% due to the company's huge growth prospects. I strongly believe that the corrective phase in the stock is an excellent buying opportunity with ~25% upside potential over the next one year.

Company Overview

Align designs, manufactures and markets the Invisalign system, a proprietary method for treating malocclusion. A malocclusion

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
Money back guarantee. Seeking Alpha PRO members receive a no-questions-asked refund for membership on months paid and not used. Details